Literature DB >> 22037268

Single nucleotide polymorphism WRN Leu1074Phe is associated with prostate cancer susceptibility in Chinese subjects.

Lei Wang1, Haruki Kaku, Peng Huang, Kexin Xu, Kai Yang, Jiheng Zhang, Ming Li, Liping Xie, Xiaofeng Wang, Akiko Sakai, Masami Watanabe, Yasutomo Nasu, Kenji Shimizu, Hiromi Kumon, Yanqun Na.   

Abstract

Deficiencies in the human DNA repair gene WRN are the cause of Werner syndrome, a rare autosomal recessive disorder characterized by premature aging and a predisposition to cancer. This study evaluated the association of WRN Leu1074Phe (rs1801195), a common missense single nucleotide polymorphism in WRN, with prostate cancer susceptibility in Chinese subjects. One hundred and forty-seven prostate cancer patients and 111 male cancer-free control subjects from 3 university hospitals in China were included. Blood samples were obtained from each subject, and the single nucleotide polymorphism WRN Leu1074Phe was genotyped by using a Snapshot assay. The results showed that WRN Leu1074Phe was associated with the risk of prostate cancer in Chinese men and that the TG/GG genotype displayed a decreased prevalence of prostate cancer compared with the TT genotype (OR=0.58, 95%CI:0.35-0.97, p=0.039). Through stratified analysis, more significant associations were revealed for the TG/GG genotype in the subgroup with diagnosis age ≤ 72 yr (OR=0.27, 95%CI:0.12-0.61, p=0.002) and in patients with localized diseases (OR=0.36, 95%CI:0.19-0.70, p=0.003). However, no statistically significant difference was found in the subgroup with age >72 yr or in patients with advanced diseases. We concluded that the genetic variant Leu1074Phe in the DNA repair gene WRN might play a role in the risk of prostate cancer in Chinese subjects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22037268

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  5 in total

Review 1.  RecQ Helicase Somatic Alterations in Cancer.

Authors:  Megha K Thakkar; Jamie Lee; Stefan Meyer; Vivian Y Chang
Journal:  Front Mol Biosci       Date:  2022-06-15

2.  Different non-synonymous polymorphisms modulate the interaction of the WRN protein to its protein partners and its enzymatic activities.

Authors:  Jean-Philippe Gagné; Sophie Lachapelle; Chantal Garand; Serges P Tsofack; Yan Coulombe; Marie-Christine Caron; Guy G Poirier; Jean-Yves Masson; Michel Lebel
Journal:  Oncotarget       Date:  2016-12-27

3.  Homozygosity for the WRN Helicase-Inactivating Variant, R834C, does not confer a Werner syndrome clinical phenotype.

Authors:  Ashwini S Kamath-Loeb; Diego G Zavala-van Rankin; Jeny Flores-Morales; Mary J Emond; Julia M Sidorova; Alessandra Carnevale; Maria Del Carmen Cárdenas-Cortés; Thomas H Norwood; Raymond J Monnat; Lawrence A Loeb; Gabriela E Mercado-Celis
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

4.  Rare case of apatinib acquired resistance induced by point mutation of WRN p.V697F through activation of the PI3K/AKT apoptosis-inhibiting pathway.

Authors:  Ruofei Yu; Hua Bai; Bingyu Gao; Tangai Li; Xiran He; Pei Zhang; Jie Wang
Journal:  Thorac Cancer       Date:  2020-11-22       Impact factor: 3.500

5.  Significant association between the Axin2 rs2240308 single nucleotide polymorphism and the incidence of prostate cancer.

Authors:  Chao Ma; Chunxiao Liu; Peng Huang; Haruki Kaku; Jie Chen; Kai Guo; Hideo Ueki; Akiko Sakai; Yasutomo Nasu; Hiromi Kumon; Kenji Shimizu; Masami Watanabe
Journal:  Oncol Lett       Date:  2014-05-26       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.